Sage Journals: Discover world-class research

Free access

Review article

First published 2014-10

Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes

Bernard Peene, Katrien Benhalima

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Research article

First published 2024-12

Evaluation of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Prescribing Patterns in Heart Failure Patients at Hospital Discharge

Emily Wo, Cara Trulli, Jessica Wilczynski [...]

Journal of Pharmacy Practice

Free access

Research article

First published 2015-3

Development of sotagliflozin,a dual sodium-dependent glucose transporter 1/2 inhibitor

Pablo Lapuerta, Brian Zambrowicz, Paul Strumph [...]

Diabetes & Vascular Disease Research

Open access

Case report

First published 2022

The Use of SGLT-2 Inhibitors Coupled With a Strict Low-Carbohydrate Diet: A Set-Up for Inducing Severe Diabetic Ketoacidosis

Helpees Guirguis, Shiela Beroukhim Afrahimi, Charles Pham

Clinical Medicine Insights: Case Reports

Retricted access

Review article

First published 2021-4

Review of Newer Antidiabetic Agents for Diabetes Management in Kidney Transplant Recipients

Sonya Anderson, Laura Cotiguala, Sarah Tischer [...]

Annals of Pharmacotherapy

Open access

Review article

First published 2023

A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke

Fotios Barkas, Georgia Anastasiou, George Liamis [...]

Therapeutic Advances in Endocrinology and Metabolism

Open access

Research article

First published 2024

Neomangiferin,a Naturally Occurring Mangiferin Congener,Inhibits Sodium-Glucose Co-transporter-2: An In silico Approach

Ayobami J Olusola, Samson O Famuyiwa, Kolade O Faloye [...]

Bioinformatics and Biology Insights

Retricted access

Research article

First published 2025-1

Investigating the impact of empagliflozin on the retina of diabetic mice

Juan Chen, Shenghui Zhang, Yao You [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2025-5

Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ 1–42 -induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease

Mehdi Alami, Echarki Zerif, Abdelouahed Khalil [...]

Journal of Alzheimer’s Disease

Open access

Research article

First published 2021

Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM

Aml Mohamed Nada, Mariam Adel Younan

Therapeutic Advances in Endocrinology and Metabolism

Search results